+

PE20030539A1 - Derivados de piperazina antagonistas de los receptores de somatostatina sst1 - Google Patents

Derivados de piperazina antagonistas de los receptores de somatostatina sst1

Info

Publication number
PE20030539A1
PE20030539A1 PE2002001085A PE2002001085A PE20030539A1 PE 20030539 A1 PE20030539 A1 PE 20030539A1 PE 2002001085 A PE2002001085 A PE 2002001085A PE 2002001085 A PE2002001085 A PE 2002001085A PE 20030539 A1 PE20030539 A1 PE 20030539A1
Authority
PE
Peru
Prior art keywords
receptors
piperazine derivatives
alkyl
methyl
sst1
Prior art date
Application number
PE2002001085A
Other languages
English (en)
Inventor
Thomas J Troxler
Daniel Hoyer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20030539A1 publication Critical patent/PE20030539A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/90—Xanthenes with hydrocarbon radicals, substituted by amino radicals, directly attached in position 9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • C07D335/12—Thioxanthenes
    • C07D335/20—Thioxanthenes with hydrocarbon radicals, substituted by amino radicals, directly attached in position 9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)

Abstract

SE REFIERE A DERIVADOS DE PIPERAZINA DE FORMULA I DONDE X ES UN ENLACE, O, S, CH2, HC=CH, H2C-CH2; R1 ES ALQUILO, ALQUENILO, CICLOALQUILO-ALQUILO; R2 ES UN GRUPO BENCIL SUSTITUIDO CON R3 Y R4, PIRIDIL SUSTITUIDO CON R3, GRUPO b, d, e; Y ES O, S,; R3 Y R4 SON H, OH, HALOGENO, CITRO, CIANO, TRIFLUOROMETILO, ALQUILO, ALCOXI; R5 ES H, ALQUILO. SON COMPUESTOS PREFERIDOS 1-[4-(3,4-DIFLUORO-FENIL)-PIPERAZIN-1-IL]-3-{METIL[2-(9H-XANTEN-9-IL)ETIL]AMINO}-PROPAN-1-ONA; 1-[4-(3,4-DIFLUORO-FENIL)-PIPERAZIN-1-IL]-3-{METIL[2-(9H-FLUOREN-9-IL)ETIL]METIL-AMINO}-PROPAN-1-ONA. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. LOS COMPUESTOS SON ANTAGONISTAS SELECTIVOS DE RECEPTORES SST1 DE SOMATOSTATINA Y PUEDEN SER UTILES PARA EL TRATAMIENTO DE DEPRESION, ANSIEDAD, PADECIMIENTOS BIPOLARES
PE2002001085A 2001-11-09 2002-11-07 Derivados de piperazina antagonistas de los receptores de somatostatina sst1 PE20030539A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0127008.1A GB0127008D0 (en) 2001-11-09 2001-11-09 Organic compounds

Publications (1)

Publication Number Publication Date
PE20030539A1 true PE20030539A1 (es) 2003-08-13

Family

ID=9925528

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002001085A PE20030539A1 (es) 2001-11-09 2002-11-07 Derivados de piperazina antagonistas de los receptores de somatostatina sst1

Country Status (17)

Country Link
US (1) US7271168B2 (es)
EP (1) EP1446399B1 (es)
JP (1) JP4199668B2 (es)
CN (1) CN1269811C (es)
AR (1) AR037521A1 (es)
AT (1) ATE294787T1 (es)
BR (1) BR0213990A (es)
CA (1) CA2465680A1 (es)
DE (1) DE60204044T2 (es)
ES (1) ES2240830T3 (es)
GB (1) GB0127008D0 (es)
HK (1) HK1068338A1 (es)
MY (1) MY136297A (es)
PE (1) PE20030539A1 (es)
PT (1) PT1446399E (es)
TW (1) TWI259085B (es)
WO (1) WO2003040125A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7390813B1 (en) 2001-12-21 2008-06-24 Xenon Pharmaceuticals Inc. Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
BRPI0515500A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados piridazina para inibição de estearoil-coa-desaturase
BRPI0515505A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados heterocìclicos e sua utilização como inibidores da estearoil-coa desaturase
JP5094398B2 (ja) 2004-09-20 2012-12-12 ゼノン・ファーマシューティカルズ・インコーポレイテッド 複素環式誘導体およびステアロイル−ＣｏＡデサチュラーゼのメディエータとしてのそれらの使用
US7547698B2 (en) 2004-09-20 2009-06-16 Xenon Pharmaceuticals Inc. Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)
BRPI0515482A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seus usos como agentes terapêuticos
MX2007003318A (es) 2004-09-20 2007-05-18 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
CN101084211A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为治疗剂的用途
CA2580856A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
US8541457B2 (en) 2005-06-03 2013-09-24 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors
GB0514615D0 (en) 2005-07-15 2005-08-24 Novartis Ag Organic compounds
PT2355822E (pt) 2008-11-19 2013-01-14 Envivo Pharmaceuticals Inc Tratamento de distúrbios cognitivos com (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida e sais farmaceuticamente aceitáveis desta
RS54742B1 (sr) 2010-05-17 2016-10-31 Forum Pharmaceuticals Inc Kristalni oblik (r)-7-hlor-n-(hinuklidin-3-il)benzo[b]tiofen-2-karboksamid hidrohlorid monohidrata
RU2017136693A (ru) 2012-05-08 2019-02-08 Форум Фармасьютикалз, Инк. Способы поддержания, лечения или улучшения когнитивной функции

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5495047A (en) * 1991-07-10 1996-02-27 Merck, Sharp & Dohme (Ltd.) Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy

Also Published As

Publication number Publication date
WO2003040125A1 (en) 2003-05-15
AR037521A1 (es) 2004-11-17
CN1596251A (zh) 2005-03-16
DE60204044D1 (de) 2005-06-09
PT1446399E (pt) 2005-09-30
MY136297A (en) 2008-09-30
HK1068338A1 (en) 2005-04-29
TW200300088A (en) 2003-05-16
ES2240830T3 (es) 2005-10-16
EP1446399A1 (en) 2004-08-18
BR0213990A (pt) 2004-08-31
GB0127008D0 (en) 2002-01-02
JP4199668B2 (ja) 2008-12-17
JP2005516898A (ja) 2005-06-09
CN1269811C (zh) 2006-08-16
TWI259085B (en) 2006-08-01
EP1446399B1 (en) 2005-05-04
US20060079527A1 (en) 2006-04-13
CA2465680A1 (en) 2003-05-15
US7271168B2 (en) 2007-09-18
ATE294787T1 (de) 2005-05-15
DE60204044T2 (de) 2006-01-19

Similar Documents

Publication Publication Date Title
PE20030539A1 (es) Derivados de piperazina antagonistas de los receptores de somatostatina sst1
PE20011114A1 (es) Decahidro-isoquinolinas
EA200300064A1 (ru) Карбоксамидные соединения и их применение в качестве антагонистов 11cby-рецептора человека
YU8703A (sh) Derivati 4-fenil-piridina kao antagonisti receptora neurokinina-1
AR004516A1 (es) Derivados de pirimidina, su uso, procedimientos para prepararlos y medicamentos que los contienen
PE20010741A1 (es) Derivados de piperazina como antagonistas de taquicininas
PE20020298A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona como antagonistas de receptores de neuroquinina nk-1
PE20001467A1 (es) Derivados de 4-fenilpiridina como antagonistas del receptor de neuroquinina
MXPA05011710A (es) Derivados de pirimidina con actividad de crf.
CY1105688T1 (el) Κυανοπυρρολες ως αγωνιστες υποδοχεων προγεστερονης
PE20010009A1 (es) Derivados de fenil - y piridinilo como antagonistas del receptor de la neuroquinina 1
PE20001483A1 (es) Acidos oxamicos y derivados como ligandos de receptores tiroideos
ATE139233T1 (de) Annelierte thiophen-derivate, ihre herstellung und verwendung
EA200300619A1 (ru) Серотонинергические средства
BR0008056A (pt) Pirrolocarbazóis e isoindolonas cìclicas fundidas substituìdas
PE20010039A1 (es) Derivados de esteres del acido carbamico como agonistas y/o antagonistas del receptor metabotropico del glutamato
PE58399A1 (es) Atropisomeros de 3-aril-4(3h)-quinazolinonas
PE20030238A1 (es) Uso de los antagonistas del receptor nk-1 para el tratamiento de lesiones cerebrales, espinales y neuronales
PE20050420A1 (es) Fenacilo 2-hidroxi-3-diaminoalcanos
NZ528997A (en) Sulfonamides
PE20050587A1 (es) Derivados de diazindol-dicarbonilo-piperazinilo como agentes antivirales
DK1189900T3 (da) Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler
PE20010153A1 (es) Derivados de 4-fenil-pirimidina como antagonistas del receptor de neuroquinina
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
JO2235B1 (en) Derivatives of phenyl

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载